trending Market Intelligence /marketintelligence/en/news-insights/trending/rR2wLrf8RhQNwrjT4LZ0pg2 content esgSubNav
In This List

Galena Biopharma, Cardinal Health settle product swap disputes

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Galena Biopharma, Cardinal Health settle product swap disputes

Galena Biopharma Inc. agreed to settle all of its outstanding disputes with Cardinal Health Inc. over a product swap agreement.

Under the deal, Galena Biopharma will pay $500,000 to Cardinal Health. In turn, Cardinal Health will destroy all of the Zuplenz product returned due to the product swap. The related product swap agreement was also terminated as of the settlement date.

The companies entered into the agreement Sept. 25.